People: Amneal Pharmaceuticals Inc (AMRX.N)

AMRX.N on New York Stock Exchange

3 Dec 2020
Change (% chg)

$0.06 (+1.49%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Patel, Chintu 

Mr. Chintu Patel serves as Co-Chief Executive Officer, Co-Founder, Director of the Company. Mr. Chintu Patel has served as Co-Chief Executive Officer and director of the Company since August 2019. He served as a Co-Chairman of the Board from May 2018 to August 2019, and previously served as Co-Chairman and Co-Chief Executive Officer of Amneal from 2002 until the Combination. Mr. Patel holds a bachelor’s degree in pharmacy from Rutgers College of Pharmacy. He also holds an honorary doctorate degree from Long Island University. With his brother, Chirag Patel, Mr. Patel built the Amneal Alliance including Kashiv Biosciences, LLC (“Kashiv”) (engaged in the development of pharmaceutical and biosimilar pharmaceutical products), Asana Biologics, LLC (“Asana”) (an early stage drug discovery and R&D company focusing on several therapeutic areas, including oncology, pain and inflammation) and Prolong Pharmaceuticals, LLC (“Prolong”) (an early stage biotechnology company focused on new branded hematology and oncology products). Mr. Patel serves on the board of managers of each of these companies. Mr. Patel also serves on the boards of Long Island University, the Long Island Association and the Make-a-Wish Foundation®, and is a recipient of the Ernst & Young National Entrepreneur of the Year Life Sciences Award®.

Basic Compensation

Total Annual Compensation, USD 44,226
Restricted Stock Award, USD 90,749
Long-Term Incentive Plans, USD --
All Other, USD 204,625
Fiscal Year Total, USD 339,600

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --